These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 5264814

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Asparaginase, 1969].
    Boiron M, Levy D.
    Pathol Biol (Paris); 1969 Dec; 17(23):1129-32. PubMed ID: 4908018
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia.
    Burns CP.
    Cancer Chemother Rep; 1975 Dec; 59(4):757-60. PubMed ID: 1100227
    [No Abstract] [Full Text] [Related]

  • 29. Repeated use of L-asparaginase in multi-drug therapy of childhood leukemia.
    Trueworthy RC, Sutow WW, Pullen J, Komp D, Berry DH.
    Med Pediatr Oncol; 1978 Dec; 4(2):91-7. PubMed ID: 275534
    [Abstract] [Full Text] [Related]

  • 30. L-asparaginase and human malignant disease.
    Crowther D.
    Nature; 1971 Jan 15; 229(5281):168-71. PubMed ID: 4923259
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Treatment of acute leukemia with L-asparaginase.
    Loeb E, Hill JM, Hill NO, MacLellan A, Khan A, Alexander TR, Adachi A.
    Recent Results Cancer Res; 1970 Jan 15; 33():204-18. PubMed ID: 5292717
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Immunization against L-asparaginase. Demonstration and characteristics of antibodies. Clinical value].
    Marsalet YD, Lambert G, Hornez JP, Bauters F, Goudemand M.
    Nouv Presse Med; 1973 Jun 09; 2(23):1575-8. PubMed ID: 4197351
    [No Abstract] [Full Text] [Related]

  • 38. [Asparaginase, leukemia and cancer].
    Levy D, Boiron M.
    Bull Cancer; 1969 Jun 09; 56(4):365-74. PubMed ID: 4928248
    [No Abstract] [Full Text] [Related]

  • 39. [Use of L-asparaginase in therapy with special reference to acute lymphatic leukemia].
    Storti E, Fontana G.
    Minerva Med; 1972 Mar 31; 63(24):1445-56. PubMed ID: 4502507
    [No Abstract] [Full Text] [Related]

  • 40. Observations on the plasma amino acids of patients with acute leukemia.
    Rudman D, Vogler WR, Howard CH, Gerron GG.
    Cancer Res; 1971 Aug 31; 31(8):1159-65. PubMed ID: 5285976
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.